Ken Frasier, Former Chairman/CEO of Lansdale’s Merck, Joins California Healthcare Tech Firm’s BoD

Transcarent's Ken Frasier
Image via Business Wire at Transcarent.
Ken Frasier, now on the board of directors for California healthcare-tech firm Transcarent.

North Philadelphia-native Ken Frasier, former Chairman and CEO of Merck (with a Montgomery County presence in Lansdale and West Point), has joined the board of directors of Transcarent. The healthcare-technology firm operates out of Palo Alto, California.

Company CEO Glen Tullman called characterized Frazier’s healthcare and business background as “unparalleled.”

Frazier is also a tireless advocate for social justice and economic inclusion.

He co-founded and currently serves as co-chair of OneTen, a coalition of leading organizations committed to upskilling, hiring, and promoting one million Black Americans who lack four-year college degrees into family-sustaining jobs.

Transcarent is a OneTen member.

Frasier’s work toward this ambitious organizational goal was most likely a factor in his inclusion in the 2021 Time magazine list of 100 Most Influential People.

“I’m not sure there is a problem more pressing than the accessibility and affordability of health and care to the average American worker,” said Frazier. “I’m excited to join the Transcarent board and to be part of an organization that is uniquely positioned to not only improve health and care delivery, but will do so in a way that makes it more equitable for the individual as well as their employer.”


This Week in Health IT explores the patient experience with Glen Tullman of Transcarent.

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.